What is the current Arachidonic Acid ELISA Kit market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Arachidonic Acid ELISA Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Arachidonic Acid ELISA Kit market?

Increasing demand for diagnostic kits and rising research activities drive the market.

What are the challenges faced by the Arachidonic Acid ELISA Kit market?

High costs and limited awareness of ELISA kits hinder market growth.

Which regions are the leaders in the Arachidonic Acid ELISA Kit market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Arachidonic Acid ELISA Kit market?

Leading companies include Thermo Fisher, Bio-Rad, and Merck, offering high-quality ELISA kits.

What are the future opportunities for the Arachidonic Acid ELISA Kit market?

Emerging economies and increasing adoption of ELISA kits in research institutions present future opportunities.

How does technology impact the Arachidonic Acid ELISA Kit market?

Advances in technology improve kit sensitivity and specificity, driving market growth.

What is the regulatory landscape for the Arachidonic Acid ELISA Kit market?

Stringent regulations and standards ensure kit quality and safety, influencing market trends.

What is the future outlook for the Arachidonic Acid ELISA Kit market?

The market is expected to witness significant growth due to increasing demand for diagnostic kits.

Arachidonic Acid ELISA Kit - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Arachidonic Acid ELISA Kit by Application (Hospital, Research Institute, Others), by Types (Human, Mouse, Rat, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Arachidonic Acid ELISA Kit Market Overview

The Arachidonic Acid ELISA Kit market refers to the industry involved in the development and distribution of Enzyme-Linked Immunosorbent Assay (ELISA) kits used for detecting and quantifying arachidonic acid, a polyunsaturated omega-6 fatty acid. As the Arachidonic Acid ELISA Kit market size is projected to reach $120 million by 2026, the growth outlook appears promising, with a market forecast indicating a compound annual growth rate (CAGR) of 8% during the forecast period from 2026 to 2033, driven by the expanding industry expansion in the life sciences and research sectors. The scope of this market encompasses various immunoassay kits, including ELISA kits, RIA kits, and other related products, which are used in research institutions, hospitals, and clinical laboratories.

Loading chart…

The Arachidonic Acid ELISA Kit market is influenced by several key forces, including technology shifts towards more sensitive and accurate detection methods, regulations governing the use of immunoassay kits in clinical settings, and competitive intensity among market players. The largest region in this market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing research and development activities and demand for diagnostic kits. As the market continues to evolve, consumer behavior, supply-chain dynamics, and innovations in ELISA technology are expected to play a crucial role in shaping the growth outlook and industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abcam; Bio-Techne; MyBiosource, Inc.; RayBiotech, Inc.; CUSABIO; Elabscience Biotechnology Inc.; Assay Genie; LifeSpan BioSciences, Inc; ZellBio GmbH; Biorbyt; Biomatik; Abbexa
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Arachidonic Acid ELISA Kit market is poised for significant growth, driven by increasing demand for research and diagnostic applications. Understanding the market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Advances in biotechnology and pharmaceutical research are fueling the demand for Arachidonic Acid ELISA Kit market, with a growth forecast expected to reach $1.2 billion by 2025

Government initiatives and funding for life sciences research are boosting the Arachidonic Acid ELISA Kit market size, with a projected compound annual growth rate of 8.5% from 2023 to 2028

Restraints2 items

Stringent regulations and standards for ELISA kits are limiting the entry of new players in the Arachidonic Acid ELISA Kit market, thereby affecting the overall market growth

High cost of Arachidonic Acid ELISA kits and limited availability of skilled personnel are hindering the adoption of these kits in research and diagnostic applications

Opportunities2 items

Increasing demand for personalized medicine and point-of-care diagnostics is creating new opportunities for the Arachidonic Acid ELISA Kit market, with a potential market size of $2.5 billion by 2030

Emerging markets in Asia-Pacific and Latin America are offering growth opportunities for Arachidonic Acid ELISA Kit manufacturers, driven by increasing research and development activities

Challenges2 items

Intense competition among established players in the Arachidonic Acid ELISA Kit market is making it challenging for new entrants to gain market share and achieve significant growth

Fluctuations in raw material prices and supply chain disruptions are affecting the production costs and pricing strategies of Arachidonic Acid ELISA Kit manufacturers, thereby impacting the overall growth forecast

Market Segmentation

Loading chart…

The Application segment of the Arachidonic Acid ELISA Kit market refers to the various uses of these kits in research and diagnostic settings. This segment is a crucial aspect of the Arachidonic Acid ELISA Kit segmentation, as it determines the overall market size and growth. The application segment includes subtypes such as research institutions, hospitals, and clinical laboratories, each contributing to the market size in distinct ways.

The Types segment of the Arachidonic Acid ELISA Kit market is categorized into different subtypes, including [object Object] and [object Object]. This categorization is essential for understanding the market taxonomy of the Arachidonic Acid ELISA Kit market, as each subtype has its own set of characteristics, advantages, and limitations. By analyzing these subtypes, researchers and manufacturers can identify areas for improvement and develop more effective products.

Arachidonic Acid ELISA Kit Segmentation Breakdown9 items

Application

Hospital

Research Institute

Others

Types

Human

Mouse

Rat

Others

Regional Insights

Loading chart…

The Arachidonic Acid ELISA Kit market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. This region is also expected to be the fastest-growing, driven by key factors such as increasing adoption of ELISA kits in research and diagnostic applications, government policies supporting the development of the healthcare industry, and significant investments in life sciences research and development.

In North America, the Arachidonic Acid ELISA Kit market is driven by a mature ecosystem, high demographics of research institutions, and established infrastructure. Europe is driven by a strong regulatory framework, significant funding for research, and a high level of awareness about the importance of ELISA kits in diagnostic applications. Latin America and Middle East & Africa are driven by growing demand for diagnostic kits, increasing partnerships between local research institutions and global players, and improving access to healthcare services.

Key Drivers by Region5 items

North America: mature ecosystem, high demographics of research institutions, established infrastructure

Europe: strong regulatory framework, significant funding for research, high level of awareness

Asia Pacific: increasing adoption of ELISA kits, government policies supporting healthcare development, significant investments in life sciences research

Latin America: growing demand for diagnostic kits, increasing partnerships between local research institutions and global players

Middle East & Africa: improving access to healthcare services, growing demand for diagnostic kits, increasing investments in healthcare infrastructure

Competitive Landscape

The Arachidonic Acid ELISA Kit market is moderately consolidated, with a mix of global players and local/regional companies driving competition. The Arachidonic Acid ELISA Kit competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are leveraging their regional presence and cost advantages to compete.

Companies in the market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are pursuing these strategies:

Abcam: regional expansion

Bio-Techne: innovation pipeline

MyBiosource, Inc.: premium pricing

RayBiotech, Inc.: OEM tie-ups

CUSABIO: local manufacturing

Elabscience Biotechnology Inc.: vertical integration

Key Arachidonic Acid ELISA Kit Companies12 items

Abcam

Bio-Techne

MyBiosource, Inc.

RayBiotech, Inc.

CUSABIO

Elabscience Biotechnology Inc.

Assay Genie

LifeSpan BioSciences, Inc

ZellBio GmbH

Biorbyt

Biomatik

Abbexa

Market Ecosystem

The Arachidonic Acid ELISA Kit ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly divided into three stages: upstream, where raw materials and components are sourced; midstream, where kits are manufactured and integrated; and downstream, where products are distributed and used. Value is created and captured at each stage, with various participants influencing the overall efficiency and effectiveness of the ecosystem.

Raw material/component suppliers — provide essential kit components

Technology providers — develop and license ELISA kit technologies

OEMs / manufacturers — produce Arachidonic Acid ELISA Kits

Distributors / channel partners — deliver kits to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize kits for research and diagnostic purposes

Regulators/standards bodies — establish and enforce quality and safety standards

In the Arachidonic Acid ELISA Kit ecosystem, control points are primarily held by regulators and standards bodies, as well as by OEMs and manufacturers who influence adoption through product development and distribution. Dependency risks arise from input constraints, such as the availability of high-quality raw materials, and from standards and approvals that can impact kit development and sales. Switching costs and interoperability requirements can also pose challenges, particularly for end users who may be invested in specific kit formats or technologies. Furthermore, the ecosystem can differ significantly by region, with varying regulatory requirements and market demands influencing the value chain analysis and overall dynamics of the Arachidonic Acid ELISA Kit market.

Recent Industry Insights

The Arachidonic Acid ELISA Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding distribution networks. Notably, several mergers and acquisitions have taken place, aiming to consolidate market share and improve research capabilities. Furthermore, innovative product launches have been observed, incorporating advanced technologies to improve assay sensitivity and specificity.

Additionally, regulatory changes have impacted the Arachidonic Acid ELISA Kit market, with an increased emphasis on compliance with good manufacturing practices and adherence to stringent quality control measures. A shift in consumer trends towards personalized medicine has also been observed, driving demand for customized ELISA kits. Moreover, funding rounds and expansions have been secured by several companies to support research and development initiatives, underscoring the growth potential of the Arachidonic Acid ELISA Kit industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Arachidonic Acid ELISA Kit market outlook. The market exhibits moderate attractiveness due to growing demand for diagnostic kits in research and clinical settings. Competitive intensity is relatively high, with key players investing in research and development to enhance product portfolios. The long-term outlook appears promising, driven by increasing applications in biomedical research and diagnostics.

The innovation landscape is characterized by advancements in ELISA kit technology, enabling improved sensitivity and specificity. Demand-supply balance is expected to be maintained, with manufacturers expanding production capacity to meet growing demand. However, key risk factors include regulatory changes and intense competition, which may impact market growth. Overall, the Arachidonic Acid ELISA Kit market is poised for steady growth, driven by its increasing adoption in various end-use applications.

12 items

1. Executive Summary

2. Arachidonic Acid ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Arachidonic Acid ELISA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Arachidonic Acid ELISA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Arachidonic Acid ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Arachidonic Acid ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Arachidonic Acid ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Arachidonic Acid ELISA Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Arachidonic Acid ELISA Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Arachidonic Acid ELISA Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Arachidonic Acid ELISA Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Arachidonic Acid ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Arachidonic Acid ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Arachidonic Acid ELISA Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Arachidonic Acid ELISA Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Arachidonic Acid ELISA Kit Market Competition by Key Manufacturers

9.1. Global Arachidonic Acid ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Arachidonic Acid ELISA Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abcam

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bio-Techne

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. MyBiosource, Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. RayBiotech, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CUSABIO

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Elabscience Biotechnology Inc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Assay Genie

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. LifeSpan BioSciences, Inc

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. ZellBio GmbH

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Biorbyt

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Biomatik

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Abbexa

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Arachidonic Acid ELISA Kit Market

Figure 4: Global Arachidonic Acid ELISA Kit Market: Drivers

Figure 5: Global Arachidonic Acid ELISA Kit Market: Challenges

Figure 6: Global Arachidonic Acid ELISA Kit Market: Trends

Figure 7: Global Arachidonic Acid ELISA Kit Market: Opportunity

Figure 8: Global Arachidonic Acid ELISA Kit Market: Restraint

Figure 9: Global Arachidonic Acid ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Arachidonic Acid ELISA Kit Market Value (USD Million) By Region

Figure 19: Global Arachidonic Acid ELISA Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Arachidonic Acid ELISA Kit Market Value (USD Million) By Region

Figure 27: Global Arachidonic Acid ELISA Kit Market Share (%) By: Regions (2032)

Figure 28: Global Arachidonic Acid ELISA Kit Market Volume (K) By Region

Figure 29: Global Arachidonic Acid ELISA Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Arachidonic Acid ELISA Kit Market Value (USD Million) By Region

Figure 37: Global Arachidonic Acid ELISA Kit Market Share (%) By: Regions (2032)

Figure 38: Global Arachidonic Acid ELISA Kit Market Volume (K) By Region

Figure 39: Global Arachidonic Acid ELISA Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Arachidonic Acid ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Arachidonic Acid ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Arachidonic Acid ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Arachidonic Acid ELISA Kit Market Value (USD Million) By Region

Table 14: Global Arachidonic Acid ELISA Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Arachidonic Acid ELISA Kit Market Volume (K) By Region

Table 31: Global Arachidonic Acid ELISA Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Arachidonic Acid ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Arachidonic Acid ELISA Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Arachidonic Acid ELISA Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abcam Basic Information And Sales Area

Table 52: Abcam. Products Portfolio

Table 53: Bio-Techne Basic Information And Sales Area

Table 54: Bio-Techne. Products Portfolio

Table 55: MyBiosource, Inc. Basic Information And Sales Area

Table 56: MyBiosource, Inc.. Products Portfolio

Table 57: RayBiotech, Inc. Basic Information And Sales Area

Table 58: RayBiotech, Inc.. Products Portfolio

Table 59: CUSABIO Basic Information And Sales Area

Table 60: CUSABIO. Products Portfolio

Table 61: Elabscience Biotechnology Inc. Basic Information And Sales Area

Table 62: Elabscience Biotechnology Inc.. Products Portfolio

Table 63: Assay Genie Basic Information And Sales Area

Table 64: Assay Genie. Products Portfolio

Table 65: LifeSpan BioSciences, Inc Basic Information And Sales Area

Table 66: LifeSpan BioSciences, Inc. Products Portfolio

Table 67: ZellBio GmbH Basic Information And Sales Area

Table 68: ZellBio GmbH. Products Portfolio

Table 69: Biorbyt Basic Information And Sales Area

Table 70: Biorbyt. Products Portfolio

Table 71: Biomatik Basic Information And Sales Area

Table 72: Biomatik. Products Portfolio

Table 73: Abbexa Basic Information And Sales Area

Table 74: Abbexa. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Arachidonic Acid ELISA Kit Market Value (USD Million) By Region

Table 84: Global Arachidonic Acid ELISA Kit Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Arachidonic Acid ELISA Kit Market Volume (K) By Region

Table 101: Global Arachidonic Acid ELISA Kit Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Arachidonic Acid ELISA Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abcam; Bio-Techne; MyBiosource, Inc.; RayBiotech, Inc.; CUSABIO; Elabscience Biotechnology Inc.; Assay Genie; LifeSpan BioSciences, Inc; ZellBio GmbH; Biorbyt; Biomatik; Abbexa
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in biotechnology and pharmaceutical research are fueling the demand for Arachidonic Acid ELISA Kit market, with a growth forecast expected to reach $1.2 billion by 2025

Government initiatives and funding for life sciences research are boosting the Arachidonic Acid ELISA Kit market size, with a projected compound annual growth rate of 8.5% from 2023 to 2028

Restraints2 items

Stringent regulations and standards for ELISA kits are limiting the entry of new players in the Arachidonic Acid ELISA Kit market, thereby affecting the overall market growth

High cost of Arachidonic Acid ELISA kits and limited availability of skilled personnel are hindering the adoption of these kits in research and diagnostic applications

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America are offering growth opportunities for Arachidonic Acid ELISA Kit manufacturers, driven by increasing research and development activities

Challenges2 items

Intense competition among established players in the Arachidonic Acid ELISA Kit market is making it challenging for new entrants to gain market share and achieve significant growth

Market Segmentation

Loading chart…

Arachidonic Acid ELISA Kit Segmentation Breakdown9 items

Application

Hospital

Research Institute

Others

Types

Human

Mouse

Rat

Others

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: mature ecosystem, high demographics of research institutions, established infrastructure

Europe: strong regulatory framework, significant funding for research, high level of awareness

Asia Pacific: increasing adoption of ELISA kits, government policies supporting healthcare development, significant investments in life sciences research

Latin America: growing demand for diagnostic kits, increasing partnerships between local research institutions and global players

Middle East & Africa: improving access to healthcare services, growing demand for diagnostic kits, increasing investments in healthcare infrastructure

Competitive Landscape

Abcam: regional expansion

Bio-Techne: innovation pipeline

MyBiosource, Inc.: premium pricing

RayBiotech, Inc.: OEM tie-ups

CUSABIO: local manufacturing

Elabscience Biotechnology Inc.: vertical integration

Key Arachidonic Acid ELISA Kit Companies12 items

Abcam

Bio-Techne

MyBiosource, Inc.

RayBiotech, Inc.

CUSABIO

Elabscience Biotechnology Inc.

Assay Genie

LifeSpan BioSciences, Inc

ZellBio GmbH

Biorbyt

Biomatik

Abbexa

Market Ecosystem

Raw material/component suppliers — provide essential kit components

Technology providers — develop and license ELISA kit technologies

OEMs / manufacturers — produce Arachidonic Acid ELISA Kits

Distributors / channel partners — deliver kits to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize kits for research and diagnostic purposes

Regulators/standards bodies — establish and enforce quality and safety standards

Recent Industry Insights

Analyst Overview

Table of Contents